Solventum Corp (NYSE: SOLV)

Solventum Corp is a global healthcare company that develops, manufactures, and commercializes a broad portfolio of solutions leveraging deep material science, data science, and digital capabilities to address critical customer and patient needs. The company operates in the healthcare industry, focusing on improving standards of care through innovation powered by insights, clinical intelligence, technology, and manufacturing expertise. With a 70-year history, Solventum has established itself as a key player in solving some of the toughest challenges in healthcare, providing solutions that are relied upon daily to deliver higher-quality patient care, more efficient processes, and improved standards of safety and accuracy.

Solventum generates revenue through its diverse portfolio of healthcare solutions, which include negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, medical technologies Original Equipment Manufacturer (OEM), dental and orthodontic products, and health information systems software solutions. These products cater to a wide range of customers, including multidisciplinary hospitals, local clinics, and practices, serving both the prevention and treatment aspects of patient care.

• MedSurg (57.9% of 2025 total sales): This segment provides a comprehensive range of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies OEM. These solutions are designed to accelerate healing, prevent complications, and lower the total cost of care, catering to the medical and surgical needs of healthcare providers.

• Dental Solutions (16.2% of 2025 total sales): This segment offers a suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. These products span the "life of the tooth," addressing preventative dental care, direct and indirect restoration, and broad orthodontic needs, catering to dental professionals and patients.

• Health Information Systems (16.3% of 2025 total sales): This segment provides healthcare systems with software solutions including computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. These solutions are designed to eliminate revenue cycle waste, create more time for patient care, and support value-based care, catering to healthcare administrators and providers.

Solventum holds a strong position within the healthcare industry, competing with key players such as Smith & Nephew, Medaxis, Mölnycke, Coloplast, Convatec, Becton Dickinson, Hartmann, ICU Medical, Medline, Cardinal Health, Fortive, Steris, MDF Instruments, BSN, Dentsply Sirona, Envista, Straumann, Ivoclar, Align Technology, Optum, Microsoft (Nuance), Epic, Oracle (Cerner), Waystar, and Athena. The company's competitive advantages include strong customer relationships, a broad and well-known portfolio of brands, differentiated technology, and manufacturing expertise. These factors enable Solventum to drive stronger customer retention and create multiple avenues for further customer engagement.

The company's customer base is diverse, ranging from multidisciplinary hospitals to local clinics and practices. Solventum's long-tenured and collaborative customer relationships globally provide unique insights into their needs and preferences, which inform the company's innovation processes. This customer-centric approach ensures that Solventum's solutions are tailored to meet the evolving demands of the healthcare industry, ultimately improving patient outcomes and operational efficiency.